|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Wilson’s disease显示文摘 | Aftab Ala Ann P Walker Keyoumars Ashkan James S Dooley Michael L Schilsky | 2007 | The Lancet . 2007 (9559)2007，，9559： | 3 |
| 2 | Split-dose menthol-enhanced PEG vs PEG-ascorbic acid for colonoscopy preparation显示文摘AIM:To compare the efficacy and palatability of 4L polyethylene glycol electrolyte(PEG)plus sugar-free menthol candy(PEG+M)vs reduced-volume 2 L ascorbic acid-supplemented PEG(Asc PEG).METHODS:In a randomized controlled trial setting,ambulatory patients scheduled for elective colonoscopy were prospectively enrolled.Patients were randomized to receive either PEG+M or Asc PEG,both splitdosed with minimal dietary restriction.Palatability was assessed on a linear scale of 1 to 5(1=disgusting;5=tasty).Quality of preparation was scored by assignment-blinded endoscopists using the modified Aronchick and Ottawa scales.The main outcomes were the palatability and efficacy of the preparation.Secondary outcomes included patient willingness to retake the same preparation again in the future and completion of the prescribed preparation.RESULTS:Overall,200 patients were enrolled(100patients per arm).PEG+M was more palatable than Asc PEG(76%vs 62%,P=0.03).Completing the preparation was not different between study groups(91%PEG+M vs 86%Asc PEG,P=0.38)but more patients were willing to retake PEG+M(54%vs 40%respectively,P=0.047).There was no significant difference between PEG+M vs Asc PEG in adequate cleansing on both the modified Aronchick(82%vs77%,P=0.31)and the Ottawa scale(85%vs 74%,P=0.054).However,PEG+M was superior in the left colon on the Ottawa subsegmental score(score0-2:94%for PEG+M vs 81%for Asc PEG,P=0.005)and received significantly more excellent ratings than Asc PEG on the modified Aronchick scale(61%vs 43%,P=0.009).Both preparations performed less well in afternoon vs morning examinations(inadequate:29%vs 15.2%,P=0.02).CONCLUSION:4 L PEG plus menthol has better palatability and acceptability than 2 L ascorbic acidPEG and is associated with a higher rate of excellentpreparations;Clinicaltrial.gov identifier:NCT01788709. | Ala I Sharara Ali H Harb Fayez S Sarkis Jean M Chalhoub Rami Badreddine Fadi H Mourad Mahmoud Othman Omar Masri | 2015 | World Journal of Gastroenterology2015，21，6： | 2 |
| 3 | Rituximab modifies the cisplatinmito-chondrial signalling pathway,resulting in apoptosis in cisplatin non-Hodgkins lymphoma显示文摘 | Alas S Ng CP Bonavida B | 2002 | Clin Cancer Res2002，8，3： | 1 |
| 4 | COL9A3 gene polymorphism and obesity inintervertebral disc degeneration of the lumbar spine: evidence of gene environment interaction显示文摘 | Solovieva S Lohiniva J Leino-Arjas P Raininko R Luoma K Ala Kokko L | 2002 | Spine ( Phila Pa 1976 )2002，27，： | 1 |
| 5 | The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stern cell self-renewal and transformation 显示文摘 | SONG S J ITO K ALA U | 2013 | Cell Stem Cell2013，13，1： | 1 |
| 6 | Enhanced electrokinetic remediation of contaminated manufactured gas plant soil 显示文摘 | Reddy K R Ala P R Sharma S | 2006 | Eng Geol2006，85，： | 1 |
| 7 | Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis显示文摘 | ALAS S BONAVIDA B | 2003 | Clin Cancer Res2003，9，： | 1 |
| 8 | IntervertebraI disc degeneration in relation to the COL9A3 and the IL-1B gene polymorphisms显示文摘 | Solovieva S Lohiniva J Leino Arias P Raininko R Luoma K Ala Kokko L | 2006 | EurSpine J2006，15，： | 1 |
| 9 | Chimeric anti-CD20(IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs显示文摘 | Demidem A Lam T Alas S | 1997 | Cancer Biother Radiopharm1997，12，3： | 1 |
| 10 | Antifreeze protein produced endogenously in winter rye leaves显示文摘 | Grifllth M Ala P Yang D S C | 1992 | Plant Physical1992，100，2： | 1 |
| 11 | Chimeric anti-CD 20 monoclonal antibody sensitizes a Bcell lymphoma cell line to cell killing by cytotoxic drugs 显示文摘 | DEMIDEM A LAM T ALAS S | 1997 | Cancer Biother Radio Pharm1997，12，3： | 1 |
| 12 | Chimeric anti-CD20 (IDEC- C2B8 ) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs 显示文摘 | Demidem A Lam T Alas S | 1997 | Cancer Biother Radiopharm1997，12，3： | 1 |
| 13 | Dextromethorphan metabolic phenotyping in an Iranian population显示文摘 | Afshar M Rouini M Ala S | 2005 | EurJ Clin Pharmaeol2005，60，12： | 1 |
| 14 | Chimeric anti-CD20(IDEC-C2B8) monoclonal antibody sensities a B cell lymphoma cell line to cell killing by cytotoxic drugs 显示文摘 | Demidem A Lam T Alas S | 1997 | Cancer Biotherapy andRadiopharmaceuticals1997，12，3： | 1 |
| 15 | Study of oscillations and pattern formation in the CO+O2 reaction on Pt(100) surfaces through dynamic Monte Carlo simulation显示文摘 | ALAS S J ZGRABLICH G | 2007 | Applied Surface Science2007，253，： | 1 |
| 16 | Response of antioxidant enzymes to transfer from elevated carbon dioxide to air and ozone fumigation, in the leaves and roots of wild-type and a catalase-deficient mutant of barley 显示文摘 | Azevedo S A Alas R M Smith R J | 1998 | Physiol Plant1998，104，： | 1 |
| 17 | Zinc and copper plasma concentrations in rheumatoid arthritis patients from a selected population in Iran Pak 显示文摘 | Ala S Shokrzadeh M Pur Shoja AM | 2009 | Pak J Biol Sci2009，12，14： | 1 |
| 18 | AFM Study of Muhilayer Sol-gel Bax Sr1-xTiO3 thin films 显示文摘 | Ala'eddin A S Ramli N Poopalan P | 2010 | Physical Review Letters2010，3，1： | 1 |
| 19 | Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs显示文摘 | Demidem A Lam T Alas S | 1997 | Cancer Biother Radiopharm1997，12，3： | 1 |
| 20 | Electrical Properties of Metal-ferroelectric-insulator-semiconductor Structure Using BaxSr1-xTiO3 for Ferroelectric-gate Field Effect Transistor 显示文摘 | Ala'eddin A S Poopalan P | 2011 | Solid-state Electronics2011，62，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员